Phase I - Serological Assays for the detection and characterization of influenza viruses
75D30125R · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Atlanta, GA, with responses due 2025-01-08. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
This contract is for one 12-month base period, and four, 12-month option periods for the testing of immunological responses of human samples collected from vaccine effectiveness studies of seasonal and pandemic influenza vaccine, randomized controlled trials of influenza vaccines, and/or outbreak in
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $2.8M | n/a | 2026-07-01 |
| BECTON, DICKINSON AND COMPANY | $21K | 1 | 2026-07-01 |
| CEPHEID | $306K | n/a | 2026-07-01 |
Questions
What is solicitation 75D30125R?
Phase I - Serological Assays for the detection and characterization of influenza viruses, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in Atlanta, GA. Responses are due 2025-01-08.
What do similar contracts close for?
Comparable closed awards in this category ran from $21K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.